Tafamidis: A Game Changer in Transthyretin Cardiomyopathy? A Systematic Review of Efficacy and Safety

被引：0
|
作者：
Hussain, Bilal
Hamza, Mohammad
Sattar, Yasar
Patel, Bansari
Song, David
Patel, Neel N.
Duhan, Sanchit
Cheema, Mustafa Sajjad
Naeem, Minahil
Waqar, Hafiza Hareem
Lactana, Sharaad
Alraies, M. Chadi C.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Amyloidosis; Mortality; Heart Failure; Echocardiography;
D O I：
10.1161/circ.148.suppl_1.16556
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16556
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Duca, F.
    Binder, C.
    Capelle, C.
    Aschauer, S.
    Eslam, R. Badr
    Mascherbauer, J.
    Hengstenberg, C.
    Bonderman, D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 494 - 494
  • [22] Treatment with Tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Christopher, M.
    Dachs, T.
    Duca, F.
    Binder, C.
    Dusik, F.
    Seirer, B.
    Eslam, R. Badr
    Hengstenberg, C.
    Bonderman, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S306 - S307
  • [23] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Christopher, M.
    Duca, F.
    Dachs, T.
    Binder, C.
    Kronberger, C.
    Dusik, F.
    Ligios, L. Camuz
    Schrutka, L.
    Dalos, D.
    Charwat-Resl, S.
    Eslam, R. Badr
    Hengstenberg, C.
    Kastner, J.
    Bonderman, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S115 - S115
  • [24] Tafamidis Stabilizes Transthyretin and Improves Clinical Outcomes in Transthyretin Amyloid Cardiomyopathy
    Falk, Rodney
    Maurer, Matthew
    Fedson, Savitri
    Judge, Daniel
    Zeldenrust, Steven
    Quyyumi, Arshed
    Pano, Arian
    Packman, Jeff
    Grogan, Donna
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S56 - S56
  • [25] Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy
    Park, Jonathan
    Egolum, Ugochukwu
    Parker, Shanea
    Andrews, Ebony
    Ombengi, David
    Ling, Hua
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (05) : 470 - 477
  • [26] Tafamidis in Transthyretin Amyloid Cardiomyopathy Effects on Transthyretin Stabilization and Clinical Outcomes
    Maurer, Mathew S.
    Grogan, Donna R.
    Judge, Daniel P.
    Mundayat, Rajiv
    Packman, Jeff
    Lombardo, Ilise
    Quyyumi, Arshed A.
    Aarts, Janske
    Falk, Rodney H.
    CIRCULATION-HEART FAILURE, 2015, 8 (03) : 519 - 526
  • [27] Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
    Gillmore, Julian D.
    Judge, Daniel P.
    Cappelli, Francesco
    Fontana, Marianna
    Garcia-Pavia, Pablo
    Gibbs, Simon
    Grogan, Martha
    Hanna, Mazen
    Hoffman, James
    Masri, Ahmad
    Maurer, Mathew S.
    Nativi-Nicolau, Jose
    Obici, Laura
    Poulsen, Steen Hvitfeldt
    Rockhold, Frank
    Shah, Keyur B.
    Soman, Prem
    Garg, Jyotsna
    Chiswell, Karen
    Xu, Haolin
    Cao, Xiaofan
    Lystig, Ted
    Sinha, Uma
    Fox, Jonathan C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (02): : 132 - 142
  • [28] Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'
    Dobner, Stephan
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04) : 681 - 682
  • [29] Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)
    Hanna, Mazen
    Damy, Thibaud
    Grogan, Martha
    Stewart, Michelle
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Maurer, Mathew S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 141 : 98 - 105
  • [30] Tafamidis and Incidence of Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy
    Girvin, Zachary P.
    Sweat, Austin O.
    Kochav, Stephanie M.
    Maurer, Mathew S.
    Dizon, Jose
    Wan, Elaine Y.
    Biviano, Angelo
    Garan, Hasan
    Yarmohammadi, Hirad
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2023, 9 (04) : 586 - 587
12345